Whalerock Point Partners’s Novartis NVS Stock Holding History

Whalerock Point Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$313K	Hold	2,050	–	–	0.06%	157
2025 Q4	$283K	Sell	2,050 -240	-10%	-$31.4K	0.05%	163
2025 Q3	$294K	Hold	2,290	–	–	0.06%	151
2025 Q2	$277K	Hold	2,290	–	–	0.06%	159
2025 Q1	$255K	Hold	2,290	–	–	0.06%	165
2024 Q4	$223K	Sell	2,290 -71	-3%	-$7.57K	0.05%	174
2024 Q3	$272K	Hold	2,361	–	–	0.06%	160
2024 Q2	$251K	Buy	2,361 +71	+3%	+$7.13K	0.07%	142
2024 Q1	$222K	Sell	2,290 -100	-4%	-$10.3K	0.06%	164
2023 Q4	$241K	Hold	2,390	–	–	0.07%	146
2023 Q3	$243K	Hold	2,390	–	–	0.08%	132
2023 Q2	$241K	Hold	2,390	–	–	0.08%	135
2023 Q1	$220K	Hold	2,390	–	–	0.08%	134
2022 Q4	$217K	Buy	+2,390	New	+$201K	0.09%	133
2022 Q3	–	Sell	-2,390	Closed	-$202K	–	139
2022 Q2	$202K	Hold	2,390	–	–	0.09%	130
2022 Q1	$210K	Hold	2,390	–	–	0.07%	137
2021 Q4	$209K	Buy	+2,390	New	+$198K	0.07%	145
2021 Q3	–	Sell	-2,390	Closed	-$218K	–	153
2021 Q2	$218K	Hold	2,390	–	–	0.08%	140
2021 Q1	$204K	Hold	2,390	–	–	0.09%	130
2020 Q4	$226K	Buy	2,390 +2,052	+607%	+$179K	0.11%	119
2020 Q3	$338K	Sell	338 -3,552	-91%	-$308K	0.19%	86
2020 Q2	$340K	Hold	3,890	–	–	0.2%	86
2020 Q1	$321K	Sell	3,890 -24	-0.6%	-$2.14K	0.23%	82
2019 Q4	$371K	Buy	3,914 +24	+0.6%	+$2.15K	0.2%	98
2019 Q3	$338K	Hold	3,890	–	–	0.18%	104
2019 Q2	$355K	Sell	3,890 -451	-10%	-$38.2K	0.2%	99
2019 Q1	$374K	Buy	4,341 +1,428	+49%	+$115K	0.24%	86
2018 Q4	$224K	Hold	2,913	–	–	0.21%	88
2018 Q3	$225K	Hold	2,913	–	–	0.16%	109
2018 Q2	$197K	Sell	2,913 -1,428	-33%	-$98.5K	0.16%	116
2018 Q1	$314K	Hold	4,341	–	–	0.1%	146
2017 Q4	$326K	Hold	4,341	–	–	0.1%	142
2017 Q3	$334K	Sell	4,341 -112	-3%	-$8.46K	0.12%	118
2017 Q2	$333K	Hold	4,453	–	–	0.12%	111
2017 Q1	$297K	Hold	4,453	–	–	0.11%	110
2016 Q4	$290K	Buy	4,453 +1,250	+39%	+$81.1K	0.11%	110
2016 Q3	$226K	Buy	+3,203	New	+$233K	0.09%	129
2016 Q1	$201K	Sell	3,102 -676	-18%	-$46K	0.09%	133
2015 Q4	$291K	Sell	3,778 -44	-1%	-$3.5K	0.13%	118
2015 Q3	$314K	Hold	3,822	–	–	0.14%	117
2015 Q2	$336K	Sell	3,822 -112	-3%	-$10.3K	0.14%	107
2015 Q1	$347K	Buy	3,934 +112	+3%	+$9.93K	0.14%	112
2014 Q4	$317K	Hold	3,822	–	–	0.13%	106
2014 Q3	$322K	Hold	3,822	–	–	0.15%	108
2014 Q2	$310K	Hold	3,822	–	–	0.15%	102
2014 Q1	$291K	Hold	3,822	–	–	0.15%	97
2013 Q4	$275K	Buy	+3,822	New	+$266K	0.14%	96

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Whalerock Point Partners's NVS Position: Q1 2026 in Review

Whalerock Point Partners held its Novartis (NVS) position steady in Q1 2026 at 2,050 shares worth $313K. The position accounts for 0.06% of the portfolio, ranked #157.

Whalerock Point Partners first reported a position in NVS in Q4 2013 and has held it in 47 quarters since. The position peaked at $374K in Q1 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Whalerock Point Partners held 2,050 shares of Novartis worth $313K as of Q1 2026.
Whalerock Point Partners left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.06% of Whalerock Point Partners's portfolio in Q1 2026, its #157 holding.
Whalerock Point Partners first reported a position in Novartis in Q4 2013 and has held it in 47 quarters since.
Whalerock Point Partners's Novartis position peaked at $374K in Q1 2019.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.